Clinical Trial Update: Moderately Preterm Infants With Caffeine at Home for Apnea (MoCHA) Trial [Phase 3]

View source ↗

Summary

A Phase 3 trial (MoCHA) evaluating caffeine citrate for apnea of prematurity in moderately preterm infants was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Apnea of Prematurity

Drugs mentioned

• Caffeine citrate (caffeine citrate)

Snippet

Sponsor: NICHD Neonatal Research Network | Conditions: Apnea of Prematurity | Phase 3 | Status: TERMINATED | Results posted: 2024-06-28